50 Jahre Universitätsklinik für Orthopädie im AKH Wien

7
Trieb K, Gerth R, Windhager R, Grohs JG, Holzer G,
Berger P, Kotz R. Serum antibodies against the heat
shock protein 60 are elevated in patients with osteosarcoma.
Immunobiology l2000;201: 368-76.
8
Trieb K, Gerth R, Holzer G, Grohs JG, Berger P, Kotz R.
Antibodies to heat shock protein 90 in osteosarcoma
patients correlate with response to neoadjuvant chemotherapy.
Br J Cancer l2000;82: 85-7.
9
Trieb K, Lechleitner T, Lang S, Windhager R, Kotz R,
Dirnhofer S. Heat shock protein 72 expression in osteosarcomas
correlates with good response to neoadjuvant
chemotherapy. Hum Pathol l1998;29: 1050-5.
10
Holzer G, Pfandlsteiner T, Blahovec H, Trieb K, Kotz
R. Serum levels of TNF-beta and sTNF-R in patients
with malignant bone tumours. Anticancer Res
l2003;23: 3057-9.
11
Holzer G, Kittl E, Pfandelsteiner T, Trieb K, Kotz R.
Concentration of soluble CD44 standard and soluble
CD44 variant V5 in the serum of patients with malignant
bone tumors. Med Pediatr Oncol l2003;40: 64-5.
12
Holzer G, Trieb K, Koschat M, Blahovec H, Kotz R.
Serum concentrations of APO-1/Fas and interleukin-
1beta-converting enzyme in osteosarcoma correlate
with response to chemotherapy. Anticancer Res
l2002;22: 1869-72.
13
Holzer G, Obermair A, Koschat M, Preyer O, Kotz R,
Trieb K. Concentration of vascular endothelial growth
factor (VEGF) in the serum of patients with malignant
bone tumors. Med Pediatr Oncol l2001;36: 601-4.
14
Trieb K, Kotz R. Proteins expressed in osteosarcoma
and serum levels as prognostic factors. Int J Biochem
Cell Biol l2001;33: 11-7.
15
Nedelcu T, Kubista B, Koller A, Sulzbacher I, Mosberger
I, Arrich F, Trieb K, Kotz R, Toma CD. Livin and
Bcl-2 expression in high-grade osteosarcoma. J Cancer
Res Clin Oncol l2008;134: 237-44.
16
Kubista B, Klinglmueller F, Bilban M, Pfeiffer M, Lass
R, Giurea A, Funovics PT, Toma C, Dominkus M, Kotz
R, Thalhammer T, Trieb K, Zettl T, Singer CF. Microarray
analysis identifies distinct gene expression
profiles associated with histological subtype in human
osteosarcoma. Int Orthop l2011;35: 401-11.
17
Kubista B, Trieb K, Sevelda F, Toma C, Arrich F, Heffeter
P, Elbling L, Sutterluty H, Scotlandi K, Kotz R,
Micksche M, Berger W. Anticancer effects of zoledronic
acid against human osteosarcoma cells. J Orthop
Res l2006;24: 1145-52.
18
Windhager R, Tsuboyama T, Siegl H, Groszschmidt
K, Seidl G, Schneider B, Plenk H, Jr. Effect of bone
cylinder length on distraction osteogenesis in the
rabbit tibia. J Orthop Res l1995;13: 620-8.
19
Windhager R, Groszschmidt K, Tsuboyama T, Siegl H,
Heinzl H, Seidl G, Plenk H, Jr. Recorticalization after
bifocal internal bone transport in the double-plated
sheep femur. J Orthop Res l1996;14: 94-101.
20
Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn
TA. Parathyroid hormone enhances fracture healing. A
preliminary report. Clin Orthop Relat Res l1999: 258-63.
21
Hofstaetter JG, Hofstaetter SG, Nawrot-Wawrzyniak
K, Hiertz H, Grohs JG, Trieb K, Windhager R, Klaushofer
K, Roschger P. Mineralization pattern of vertebral
bone material following fragility fracture of the spine.
J Orthop Res l2012.
2
Hofstaetter JG, Roschger P, Klaushofer K, Kim HK.
Increased matrix mineralization in the immature femoral
head following ischemic osteonecrosis. Bone
l2010;46: 379-85.
23
Hofstaetter JG, Wang J, Yan J, Glimcher MJ. Changes
in bone microarchitecture and bone mineral density
following experimental osteonecrosis of the hip in
rabbits. Cells Tissues Organs l2006;184: 138-47.
24
Hofstaetter JG, Wang J, Yan J, Glimcher MJ. The effects
of alendronate in the treatment of experimental
osteonecrosis of the hip in adult rabbits. Osteoarthritis
Cartilage l2009;17: 362-70.
25
Zoeger N, Streli C, Wobrauschek P, Jokubonis C,
Pepponi G, Roschger P, Hofstaetter J, Berzlanovich
A, Wegrzynek D, Chinea-Cano E, Markowicz A, Simon
R, Falkenberg G. Determination of of the elemental
distribution in human joint bones by SR micro XRF.
X-Ray Spectrom l2008: 3-11.
Fotos:
Univ.-Klinik für Orthopädie, Hofstätter
In Zusammenarbeit mit Univ.-Prof.
Dr. Klaus Klaushofer und Univ.-Doz.
Dipl.Ing. Dr. Paul Roschger vom LBI
für Osteologie, Wien und Prof. Dr.
Harry Kim, Scottish Rite Hospital
for Children in Texas/USA wurden
erstmals die Veränderungen der
Mineralisation der Knorpel und
Knochenmatrix in der nekrotischen
Epiphyse in einem experimentellen
Tiermodell des Morbus Perthes
charakterisiert.
125 Jahre Orthopädie im AKH Wien 127